Driehaus Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-510,410
Closed -$9.76M 418
2022
Q3
$9.76M Sell
510,410
-205,323
-29% -$3.74M 0.15% 196
2022
Q2
$10.9M Sell
715,733
-395,652
-36% -$5.85M 0.18% 185
2022
Q1
$22.6M Sell
1,111,385
-21,351
-2% -$435K 0.28% 129
2021
Q4
$33.1M Sell
1,132,736
-143,387
-11% -$4.1M 0.34% 96
2021
Q3
$27.5M Buy
1,276,123
+36,873
+3% +$890K 0.33% 91
2021
Q2
$31.8M Buy
1,239,250
+569,100
+85% +$12.2M 0.42% 66
2021
Q1
$12.2M Buy
+670,150
New +$11.1M 0.18% 174
2020
Q2
Sell
-88,900
Closed -$454K 488
2020
Q1
$454K Buy
88,900
+53,900
+154% +$326K 0.02% 303
2019
Q4
$268K Buy
+35,000
New +$204K 0.01% 460
2019
Q1
Sell
-773,276
Closed -$3.17M 501
2018
Q4
$3.17M Sell
773,276
-108,615
-12% -$567K 0.14% 177
2018
Q3
$6.05M Buy
+881,891
New +$5.23M 0.19% 160

Other funds holding CDMO

Driehaus Capital Management's CDMO Position: Q4 2022 in Review

Driehaus Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 510,410 shares — an estimated $9.76M sold.

Driehaus Capital Management first reported a position in CDMO in Q3 2018 and held it in 11 quarters. The position peaked at $33.1M in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Driehaus Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 510,410 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $9.76M.
  • Driehaus Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 11 quarters.
  • Driehaus Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $33.1M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Driehaus Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.